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Abstract Myosin accelerates plasminogen activation by tissue-
type plasminogen activator (tPA), and is degraded extensively by 
plasmin. Myosin binds both tPA and plasminogen, and enhances 
activation of desi 77-plasminogen by tPA but not by urokinase-
type plasminogen activator (uPA). Myosin decreases A M and 
increases kCSLt for desi 77-plasminogen activation by tPA, to 
yield catalytic efficiencies in excess of 8000 M _ 1 s _ 1 . The effect 
of myosin is attributed to its C-terminal portion, the myosin rod. 
With a KM of 3 (JM, myosin is a high-affinity substrate for 
plasmin. The findings indicate that myosin is a cofactor for 
plasminogen activation and a substrate for plasmin. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Homeostatic responses to tissue injury include vasodynamic 
reactions, hemostasis, inflammation and an extended process 
of remodeling and healing. The serine protease plasmin par-
ticipates in bridging these responses by degrading fibrin and 
possibly other extracellular proteins. Plasmin arises from plas-
minogen by proteolytic activation which, under physiological 
conditions, is inefficient in the bulk phase. Activation of plas-
minogen by tPA or uPA is enhanced by conformational or 
proteolytic modification of the zymogen [1,2]. Modifiers in-
clude some amino acids (conformational), plasmin (proteoly-
sis at Lys-77) or elastase (proteolysis between kringle 4 and 5). 
All plasminogen activators hydrolyze plasminogen between 
Arg-561 and Val-562, but tPA activity is uniquely enhanced 
by cofactors; cofactor activity has been associated with a 
diverse group of macromolecules that includes fibrin [3], poly-
amines [4], one or more endothelial cell proteins [5,6], some 
extracellular matrix components [7] and denatured proteins 
[8]. 
When tissue is injured by ischemia, infection or t rauma, 
cytosolic proteins come in contact with the fibrinolytic system. 
Among these, myosin is abundant and ubiquitous and, owing 
to its low solubility, has opportune features for participation 
in the plasminogen system. Recently actin was found to accel-
erate plasmin generation by tPA [9]. We now report that 
myosin, via its C-terminal rod domain, enhances plasminogen 
activation, and that plasmin digests myosin efficiently. 
2. Materials and methods 
Lysine-Sepharose, 6-aminohexanoate, porcine pancreatic elastase, 
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bovine and human albumin, porcine cardiac myosin and trypsin were 
obtained from Sigma Chemical Company, St. Louis, MO. Single-
chain tissue-type plasminogen activator (human melanoma), Spectro-
zyme PL (H-D-norleucylhexahydro-tyrosyllysine-p-nitroanilide) and fi-
brin(ogen) fragments were purchased from American Diagnostica, 
Hartford, CT. Two-chain uPA was obtained from Abbott Laborato-
ries, Abbot Park, IL. Characterization of porcine plasminogen acti-
vation by uPA was described earlier [2]. 
Published methods were used for preparation of rabbit skeletal 
muscle myosin, myosin fragments, myosin rod filament and fragment 
S-l [10-12]. Human plasminogen, porcine plasminogen, desi_77-plas-
minogen and des-kringlej -4-plasminogen were prepared as described 
[2,13,14]. Amino acid sequence analysis (Applied Biosystems gas-
phase sequencer) showed the N-terminal amino acid of porcine native 
plasminogen to be Asp, and that of desi_77-plasminogen an Arg res-
idue. A Pharmacia Phast48 system was used for polyacrylamide gel 
electrophoresis. 
Plasminogen activation was measured with a two-stage assay that 
precludes the influence of plasmin substrate (Spectrozyme PL) on 
activation kinetics [15,16], For steady-state kinetics, desj_77-plasmino-
gen (0.1-8 uM) was incubated with tPA (60 nM) and myosin (100^-00 
nM) in 50 mM sodium phosphate buffer, pH 7.4, at 22°C. After 20 
min, samples (10 ju.1) were diluted into 500 ul of 0.2 mM Spectrozyme 
PL dissolved in 100 mM Tris-HCl, 100 mM NaCl, pH 7.4, containing 
2.5 mM 6-aminohexanoate. The change in ^405 was measured at 22°C 
with Beckman DU-50 Spectrophotometer. Kinetic parameters were 
calculated from the Michaelis-Menten equation 
KM + S 
with use of non-linear fitting by least-square residues (Sigma Plot 5 
software, Jandel Corp., Corte Madera, CA). 
Adsorption of tPA and plasminogen to myosin was estimated by 
densitometry of NaDodSCvpolyacrylamide gels of supernatant sam-
ples taken after ultracentrifugation (105 000 Xg, 30 min, 100 ul sam-
ple, 100 mM NaCl, 100 mM Hepes, pH 7.4, 22°C). 
The KM for myosin and myosin rod with plasmin and des-
kringlei_4-plasmin were measured indirectly from competition with 
Spectrozyme PL [17]. Plasmin (60 nM) was added to solutions of 
Spectrozyme PL (2.5-320 uM) containing 0.24^17 uM myosin rod 
or 0.4-13 uM myosin in 10 mM Hepes, 100 mM NaCl, pH 7.4, 
and the change of absorbance at 405 nm was measured. The KM 
values were calculated from linear curve fits to the equation 
for two substrates competing for the enzyme, where My is the con-
centration of myosin or myosin rod and S is Spectrozyme PL. 
3. Results 
The rate of activation of native porcine plasminogen by 
tPA is increased by rabbit muscle myosin (Fig. 1). The activity 
is associated with the C-terminal port ion (rod), but not with 
the N-terminal region (S-l fragment, or head). Addit ion of 6-
aminohexanoate suppresses the rate-enhancement. Treatment 
of myosin and myosin rod with heat (90°C, 5 min) has no 
effect on enhancer activities, while S-l fragment, like some 
other denatured proteins [8], acquires activity. Contrasting 
some denatured proteins (Machovich et al., submitted) and 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 3 0 3 - 7 
94 R. Machovich et al.lFEBS Letters 407 (1997) 93-96 
Minutes 
Fig. 1. Effect of myosin and its degradation products on activation 
of native plasminogen by tPA. Native plasminogen (1.1 (iM) was 
activated with tPA (0.03 uM) in 100 mM Hepes, 50 mM NaCl, pH 
7.4. Plasmin activity was measured as absorbance at 405 nm arising 
from hydrolysis of Spectrozyme PL [16]. Additives: none (o), 0.2 
|iM rabbit skeletal muscle myosin (♦) , 0.1 |iM myosin rod (D), 0.1 
uM myosin rod plus 250 u.M 6-aminohexanoate (■), 1 uM myosin 
S-l ( A ) and 1.4 (xM native albumin (v). 
actin [9], myosin does not require plasmin digestion to devel-
op cofactor activity (not shown). 
Activation of native plasminogen by uPA is accelerated by 
both native myosin and myosin rod (Fig. 2). Relative to the 
native zymogen, desi_77-plasminogen is a more sensitive sub-
strate for both uPA and tPA, so enhancement of the plasmin-
catalyzed conversion would enhance plasmin generation in 
turn [1,2]. However, the impact of myosin rod on plasmin-
Fig. 2. Effect of myosin on native plasminogen activation by uPA. 
Native plasminogen (1.1 |xM) was activated with uPA (0.04 uM) in 
100 mM Hepes, 50 mM NaCl pH 7.4. Additives: none (o), 0.2 uM 
rabbit skeletal muscle myosin (♦) , 0.06 uM myosin rod (D) and 0.2 
(iM myosin rod (•). 
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Fig. 3. Effect of myosin rod on the proteolysis of plasminogen with 
plasmin. Native plasminogen (2.2 u\M) was incubated with plasmin 
(250 nM) and either 660 nM rabbit skeletal muscle myosin rod or 
5 mM 6-aminohexanoate. At intervals, samples were taken for SDS-
gel (10-15%) electrophoresis without reduction, a: No additives 
(control), 60 min; b-d: myosin rod, 0, 30 and 60 min; e: 6-amino-
hexanoate, 60 min. p, Native plasminogen; p', desi_77-plasminogen. 
Digestion of myosin rod by plasmin at concentrations used for co-
factor assays yields no degradation products between MT 80 000 
and 90000 (not shown). 
catalyzed conversion of native plasminogen to desi_77-plasmi-
nogen (Fig. 3e) is too small to account for its full effect on 
uPA activation (Fig. 2). 
Native myosin and myosin rod enhance activation of 
desi_77-plasminogen by tPA, while their impact on activation 
with uPA is negligible (Table 1). Steady-state kinetics of 
desi_77-plasminogen activation by tPA indicate that both rab-
bit skeletal muscle myosin and porcine cardiac myosin de-
crease KM and increase Fmax (Table 2). In the absence of 
myosin the KM of tPA for porcine deSi-77-plasminogen is 
higher than 8 nM (for human plasminogen values of 19 |J.M 
or > 100 uM are published in [3] and [9], respectively). The 
variations of the KM value at various myosin concentrations 
are not significant. Ultracentrifugation (105 000 Xg, 30 min) 
removes cofactor activity of myosin. When added prior to 
Table 1 
Effect of myosin preparations on desi_77-plasminogen activation 
Additives 
Albumin 
Myosin 
Rod 
S-l 
Ff 
Rate-enhancements (fold) 
(uPA) (tPA) 
1.3 1.7 
1.8 7 
2.2 9 
1.7 2 
10 
Desi_77-plasminogen (1.1 U.M) was activated with tPA (0.03 uM) or 
uPA (0.01 uM) in the presence of the indicated proteins (100 |J,g/ml 
each) for 30 min. 
Enhancements are relative to the rate without additives. 
Ff =fibrin(ogen) fragments. 
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Fig. 4. Degradation of myosin with proteases. Left panel: Porcine cardiac myosin (1.6 uM) was digested with human plasmin (120 nM) in 100 
mM NaOH-Hepes, 100 mM NaCl, pH 7.4. At the indicated intervals, samples were removed for analysis (Coomassie Blue staining) by poly-
acrylamide (4-15%) gel electrophoresis in NaDodS04 with reduction. Right panel: Porcine cardiac myosin (1.6 (xM) was digested with pro-
teases (200 nM, each) for 180 min under the same conditions as indicated in the left panel. Legend: p, porcine plasmin; mp, porcine des-
kringlei_4-plasmin; up, uPA; tp, tPA; el, porcine pancreatic elastase; ty, trypsin; th, porcine thrombin. 
centrifugation, desi_77-plasminogen (1 |iM) was quantitatively 
removed with cardiac myosin (2 |LM), while tPA (1 uM) was 
partially cleared (~50%). 
It is also noteworthy that, for a native protein, myosin 
appears exceptionally sensitive to degradation by plasmin 
(Fig. 4). After 60 min at 22°C, digests of myosin with plasmin 
(13:1 mol/mol), contain at least seven discrete products and 
little residual myosin (Fig. 4, left panel). Among other pro-
teases at equimolar concentrations, only trypsin catalyzes deg-
radation at a rate comparable to plasmin or des-kringlei_4-
plasmin (Fig. 4, right panel). 
By steady-state kinetic analysis, myosin is a high-affinity 
substrate for plasmin; KM values are 17 uM for Spectrozyme 
PL, 31 u\M for myosin rod, and 3.2 uM for myosin. Des-
kringlei_4-plasmin (miniplasmin), having a KM of 3.9 |iM 
with myosin, degrades myosin somewhat more extensively 
than plasmin (Fig. 4, right panel). 
4. Discussion 
Complex and protracted, the healing process that follows 
injury requires catabolism of proteins deposited both from 
plasma and from necrotic cells. Like fibrin, the contractile 
proteins are by nature insoluble and so would be expected 
Table 2 
Impact of myosin on steady-state kinetics of desi_77-plasminogen 
activation by tPA 
Myosin 
(uM) 
None 
Heart 
0.08 
0.16 
0.33 
■KM 
(MXlO6) 
> 8 
0.41 ±0.09 
0.77 ±0.25 
1.06 ±0.43 
Skeletal muscle 
0.1 
0.4 
1.04 ±0.32 
0.85±0.17 
"xat 
(s^1 X103) 
3.2 ±0.3 
5.3 ±0.6 
9.2 ±2.3 
3.2 ±0.5 
7.5± 1.8 
kcatlKu 
(M-1 s-1) 
7800 
6900 
8600 
3100 
8800 
Steady state kinetics of desi_77-plasminogen activation were measured 
and calculated as detailed in the Materials and Methods. In all assays, 
the activation rate was linear for 30 min. Without myosin, there is no 
saturation of tPA (60nM) up to 8uM desi_77-plasminogen. 
to comprise a major portion of the detritus arising from cel-
lular injury. Myosin is known to be sensitive to proteolytic 
degradation [18,19]; plasmin, like seven other proteases, yields 
three fragments from S-l and we now find that the rod like-
wise efficiently becomes highly fragmented (Fig. 4). Because 
myosin is a substrate for plasmin, the enzyme bound to my-
osin may be protected against the inhibitor system of fibrinol-
ysis like fibrin-bound plasmin [20]. Thus, the proteolytic ac-
tivities of plasmin may be very efficient under in vivo 
conditions. By simultaneously enhancing tPA activity while 
serving as a sensitive plasmin substrate, myosin shares with 
fibrin the dual properties of cofactor and substrate. Myosin 
also stimulates plasminogen activation with uPA via feedback 
proteolysis by plasmin (Table 1, Figs. 2 and 3). The efficiency 
of myosin in the facilitation of plasminogen activation by tPA 
is comparable to that of actin; in the presence of 5.7 u\M 
actin, the kelAIKyi value is 9900 M _ 1 s_ 1 [9], and in our ex-
perimental system, 0.3 u,M myosin yields a value of 8600 M _ 1 
s"1 (Table 2). 
Millimolar-range concentrations of 6-aminohexanoate facil-
itate native plasminogen activation via conformational mod-
ification of zymogen [2], whereas in micromolar concentra-
tions this amino acid and other amines inhibit the cofactor 
activity of fibrin [3], endothelial extracts [6] and denatured 
proteins [8] in the plasminogen-tPA reaction. Thus, all pro-
teins known to have a capacity to accelerate plasminogen 
activation by tPA, now including myosin, lose this capacity 
in the presence of 6-aminohexanoate. As a cofactor for plas-
minogen activation, myosin sediments with the aggregate frac-
tions and binds both plasminogen and tPA. These findings 
provide a plausible function for plasmin, tPA and possibly 
uPA in regulated general proteolysis at sites of injury. Myosin 
and actin occur in most cells, but are especially abundant in 
smooth muscle, skeletal muscle, and cardiac muscle cells and 
in platelets, all prevalent participants sites of trauma, infarc-
tion and inflammation. If means for activating plasminogen 
exists in infarcted tissue, then plasmin would provide a mech-
anism for solubilizing the major contractile proteins. If such a 
pathway does occur, then the difference in the affinity (lower 
KM) of myosin relative to myosin rod is significant, inasmuch 
as degradation of intact myosin takes precedence over later 
96 
fragments, while the fragments maintain constant tPA cofac-
tor activity. 
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